T cells dominate the intratumoral immune cell infiltrate.

<p><b>A</b>) Representative flow cytometry plots illustrating the typical gating strategy used to identify the viable immune cells in blood and tumor. <b>B</b>) The proportion of live CD45⁺ cells was calculated for each specimen. <b>C</b>) CD3⁺ T cells consistently comprised the majority of the viable immune cells in blood and tumor, while CD19⁺ B cells and non-T or B cells comprise smaller proportions.